As a research and technology transfer institute for digital medicine, Fraunhofer MEVIS—together with the Leibniz Institute for Prevention Research and Epidemiology (BIPS) and the U Bremen Research Alliance (UBRA)—calls for a change of course in its new position paper “AI4Prevention”: away from late, reactive treatment and toward early, precise prevention that spares patients unnecessary or unlikely-to-succeed interventions.